FDA panel backs first non-drug asthma treatment
Save Email Print
Bookmark and Share
Updated: 5:35 PM Oct 28, 2009
FDA panel backs first non-drug asthma treatment
Federal health advisers are recommending a novel technology from Asthmatx be approved as the first non-drug treatment for asthma.
Posted: 5:35 PM Oct 28, 2009
Reporter: Associated Press
width:200 and height: 120 and picwidth: 200 and pciheight: 120
Font Size:

WASHINGTON (AP) - Federal health advisers are recommending a
novel technology from Asthmatx be approved as the first non-drug
treatment for asthma.

The Food and Drug Administration's panel of respiratory device
experts voted 6-1 that Asthmatx's Alair System be approved under
certain conditions, including long-term tracking of patients.

The company's procedure, called thermoplasty, uses extreme heat
to burn away lung tissue that makes it difficult to breath and
causes coughing spasms and wheezing. The heat is delivered via a
catheter that emits radiofrequency waves, dissolving excess muscle.

While roughly 20 million people in the U.S. suffer from asthma,
thermoplasty would only be appropriate for about 2 million adults
who don't get relief from existing drugs.

(Copyright 2009 by The Associated Press. All Rights Reserved.)


4Warn Weatherfrom Touchstone Energy Cooperative
5day
5-DAY
temp
TEMPS
Interactive Radar
INTERACTIVE RADAR

Thursday Clouds through midday... Sunny at times in the afternoon... Chilly with ...More Details

Warnings & Watches | Text Alerts | Email Forecasts

Moms Everyday
Valentines Day Contest
Where to Watch
  • WTVY
  • WTVY2
  • WTVY3
Connect with WTVY Text Alerts Mobile Site Desktop Alert Mobile Apps RSS Feeds Enews Twitter Facebook
Buddy Check 4
WTVY.com Features
Get the ingredients you need to cook with Rach all week long.
Today's Hits, Classics & Soaps. Don't miss an episode.
Full length exclusive concerts from hot artists.
Fitness Tips
Lose Weight, Get Fit with Michele
Take a break!
Classic Pacman, Frogger, Asteroids and more.
FREE Listings
Sell almost anything locally.
In Partnership with AL.com